Thuswise, a very prominent association between FOXM1-AKT loop inactivation, HOXA genes expression, treatment sensitivity and NPM1 mutations is reproduced in multiple AML model systems and sample sets, implying that these aspects are regulated by a common circuit. This evidence concerns the gene NPM1 and acute myeloid leukemia.